Suppr超能文献

前体蛋白转化酶在严重急性呼吸综合征冠状病毒的加工和传播中的作用

Implication of proprotein convertases in the processing and spread of severe acute respiratory syndrome coronavirus.

作者信息

Bergeron Eric, Vincent Martin J, Wickham Louise, Hamelin Josée, Basak Ajoy, Nichol Stuart T, Chrétien Michel, Seidah Nabil G

机构信息

Laboratory of Biochemical Neuroendocrinology, Clinical Research Institute of Montreal, Montreal, Que., Canada H2W 1R7.

出版信息

Biochem Biophys Res Commun. 2005 Jan 21;326(3):554-63. doi: 10.1016/j.bbrc.2004.11.063.

Abstract

Severe acute respiratory syndrome coronavirus (SARS-CoV) is the etiological agent of SARS. Analysis of SARS-CoV spike glycoprotein (S) using recombinant plasmid and virus infections demonstrated that the S-precursor (proS) exists as a approximately 190 kDa endoplasmic reticulum form and a approximately 210 kDa Golgi-modified form. ProS is subsequently processed into two C-terminal proteins of approximately 110 and approximately 80 kDa. The membrane-bound proprotein convertases (PCs) furin, PC7 or PC5B enhanced the production of the approximately 80 kDa protein. In agreement, proS processing, cytopathic effects, and viral titers were enhanced in recombinant Vero E6 cells overexpressing furin, PC7 or PC5B. The convertase inhibitor dec-RVKR-cmk significantly reduced proS cleavage and viral titers of SARS-CoV infected cells. In addition, inhibition of processing by dec-RVKR-cmk completely abrogated the virus-induced cellular cytopathicity. A fluorogenically quenched synthetic peptide encompassing Arg(761) of the spike glycoprotein was efficiently cleaved by furin and the cleavage was inhibited by EDTA and dec-RVKR-cmk. Taken together, our data indicate that furin or PC-mediated processing plays a critical role in SARS-CoV spread and cytopathicity, and inhibitors of the PCs represent potential therapeutic anti-SARS-CoV agents.

摘要

严重急性呼吸综合征冠状病毒(SARS-CoV)是SARS的病原体。利用重组质粒和病毒感染对SARS-CoV刺突糖蛋白(S)进行分析表明,S前体(proS)以约190 kDa的内质网形式和约210 kDa的高尔基体修饰形式存在。ProS随后被加工成两个C末端蛋白,大小约为110 kDa和约80 kDa。膜结合的前蛋白转化酶(PCs)弗林蛋白酶、PC7或PC5B可增强约80 kDa蛋白的产生。同样,在过表达弗林蛋白酶、PC7或PC5B的重组Vero E6细胞中,proS加工、细胞病变效应和病毒滴度均增强。转化酶抑制剂dec-RVKR-cmk可显著降低SARS-CoV感染细胞的proS切割和病毒滴度。此外,dec-RVKR-cmk对加工的抑制完全消除了病毒诱导的细胞病变。包含刺突糖蛋白Arg(761)的荧光淬灭合成肽可被弗林蛋白酶有效切割,且切割受到EDTA和dec-RVKR-cmk的抑制。综上所述,我们的数据表明,弗林蛋白酶或PC介导的加工在SARS-CoV传播和细胞病变中起关键作用,PCs抑制剂代表了潜在的抗SARS-CoV治疗药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/415d/7092861/48ce1d6a4e27/gr1.jpg

相似文献

1
Implication of proprotein convertases in the processing and spread of severe acute respiratory syndrome coronavirus.
Biochem Biophys Res Commun. 2005 Jan 21;326(3):554-63. doi: 10.1016/j.bbrc.2004.11.063.
4
7
Thrombin activation of protein C requires prior processing by a liver proprotein convertase.
J Biol Chem. 2017 Jun 23;292(25):10564-10573. doi: 10.1074/jbc.M116.770040. Epub 2017 May 3.

引用本文的文献

1
Roles of host proteases in the entry of SARS-CoV-2.
Anim Dis. 2023;3(1):12. doi: 10.1186/s44149-023-00075-x. Epub 2023 Apr 25.
2
Design of Three Residues Peptides against SARS-CoV-2 Infection.
Viruses. 2022 Sep 22;14(10):2103. doi: 10.3390/v14102103.
3
Peptide-Based Vaccines and Therapeutics for COVID-19.
Int J Pept Res Ther. 2022;28(3):94. doi: 10.1007/s10989-022-10397-y. Epub 2022 Apr 19.
4
Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains.
mBio. 2021 Aug 31;12(4):e0159021. doi: 10.1128/mBio.01590-21. Epub 2021 Aug 3.
5
Exploring peptide studies related to SARS-CoV to accelerate the development of novel therapeutic and prophylactic solutions against COVID-19.
J Infect Public Health. 2021 Aug;14(8):1106-1119. doi: 10.1016/j.jiph.2021.06.017. Epub 2021 Jul 3.
6
In Vitro Models for Studying Entry, Tissue Tropism, and Therapeutic Approaches of Highly Pathogenic Coronaviruses.
Biomed Res Int. 2021 Jun 21;2021:8856018. doi: 10.1155/2021/8856018. eCollection 2021.
7
Analysis of the Contribution of Proprotein Convertases to the Processing of FGF23.
Front Endocrinol (Lausanne). 2021 Jun 4;12:690681. doi: 10.3389/fendo.2021.690681. eCollection 2021.
8
Coronavirus: Pure Infectious Disease or Genetic Predisposition.
Adv Exp Med Biol. 2021;1318:91-107. doi: 10.1007/978-3-030-63761-3_6.
9
Antiviral peptides from aquatic organisms: Functionality and potential inhibitory effect on SARS-CoV-2.
Aquaculture. 2021 Aug 30;541:736783. doi: 10.1016/j.aquaculture.2021.736783. Epub 2021 Apr 15.
10
Peptide and peptide-based inhibitors of SARS-CoV-2 entry.
Adv Drug Deliv Rev. 2020 Dec;167:47-65. doi: 10.1016/j.addr.2020.11.007. Epub 2020 Nov 13.

本文引用的文献

6
Cleavage and serum reactivity of the severe acute respiratory syndrome coronavirus spike protein.
J Infect Dis. 2004 Jul 1;190(1):91-8. doi: 10.1086/421280. Epub 2004 Jun 2.
9
Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice.
Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6641-6. doi: 10.1073/pnas.0401939101. Epub 2004 Apr 19.
10
SARS--beginning to understand a new virus.
Nat Rev Microbiol. 2003 Dec;1(3):209-18. doi: 10.1038/nrmicro775.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验